These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7975576)

  • 1. Role of neurologists in the pharmaceutical industry.
    Peroutka SJ
    West J Med; 1994 Sep; 161(3):328-30. PubMed ID: 7975576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On being a neurologist in industry.
    Leppert D; Glanzman R
    Ann Neurol; 2013 Mar; 73(3):319-26. PubMed ID: 23423974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The profession and the pharmaceutical industry.
    Koblenzer CS
    Clin Dermatol; 2005; 23(4):438-9. PubMed ID: 16023941
    [No Abstract]   [Full Text] [Related]  

  • 4. Physicians and the pharmaceutical industry (update 2001).
    Canadian Medical Association
    CMAJ; 2001 May; 164(9):1339-44. PubMed ID: 11341156
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physicians and medical visitors...evolution of a relationship].
    Daher M
    J Med Liban; 2001; 49(4):183-4. PubMed ID: 12416499
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical drug trials and the clinician].
    Saano V
    Duodecim; 1997; 113(14):1367-70. PubMed ID: 10622144
    [No Abstract]   [Full Text] [Related]  

  • 7. [The physician in the pharmaceutical industry].
    Lopes ID; Gomes MV; Branco JC
    Acta Med Port; 1993 Jul; 6(7):361-5. PubMed ID: 8379357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The function of the physician in the pharmaceutical industry].
    Vallvé C
    Med Clin (Barc); 1983 Nov; 81(16):717-9. PubMed ID: 6656427
    [No Abstract]   [Full Text] [Related]  

  • 9. Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians.
    Greenland P
    Arch Intern Med; 2009 May; 169(9):829-31. PubMed ID: 19433693
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmaceutical industry and academic medicine: opportunities for physician collaboration.
    Jefferis JE
    Circulation; 1985 Aug; 72(2 Pt 2):I21-4. PubMed ID: 3924438
    [No Abstract]   [Full Text] [Related]  

  • 11. Medicines and people in the Third World--the role of the industry. The Association of the Danish Pharmaceutical Industry (MEFA).
    Dan Med Bull; 1984 Nov; 31 Suppl 1():6-8. PubMed ID: 6518831
    [No Abstract]   [Full Text] [Related]  

  • 12. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2009; 22(1):30-8. PubMed ID: 19209297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead us not into temptation: drug representatives.
    Hagan JC
    Mo Med; 2001 Jul; 98(7):253-4. PubMed ID: 11458712
    [No Abstract]   [Full Text] [Related]  

  • 14. [Administrative organization and responsibility].
    Hilsted JC; Krogsgaard K
    Ugeskr Laeger; 2003 Apr; 165(16):1641-2. PubMed ID: 12756816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to drug development.
    Mayer D
    N Engl J Med; 2006 Nov; 355(19):2045; author reply 2046. PubMed ID: 17099949
    [No Abstract]   [Full Text] [Related]  

  • 16. The teaching of drug development to medical students: collaboration between the pharmaceutical industry and medical school.
    Stanley AG; Jackson D; Barnett DB
    Br J Clin Pharmacol; 2005 Apr; 59(4):464-74. PubMed ID: 15801942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology.
    van der Greef J; McBurney RN
    Nat Rev Drug Discov; 2005 Dec; 4(12):961-7. PubMed ID: 16341061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The physician in the pharmaceutical industry].
    Benkert K
    Fortschr Med; 1987 Aug; 105(25):480-2. PubMed ID: 3666644
    [No Abstract]   [Full Text] [Related]  

  • 19. Globalization of the pharmaceutical industry: the physician's role in optimizing drug use.
    Young MD
    J Clin Pharmacol; 1990 Nov; 30(11):990-3. PubMed ID: 2243156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The difficulties industry is facing with investigators.
    Blackledge GR
    Eur J Cancer; 2005 Oct; 41(15):2210-2. PubMed ID: 16214043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.